Balbir Singh, Yu-Cheng- Hsieh, Yen-Bing Liu, Kuo-Hung Lin, Boyoung Joung, Diego A Rodriquez, Alexandr R Chasnoits, Dejia Huang, Shu Zhang, Janet E O'Brien, Daniel Lexcen, Jeffrey Cerkvenik, Brian Van Dorn, Chi Keong Ching
BACKGROUND: & Objective: Despite the burden of sudden cardiac arrest (SCA) worldwide, implantable cardioverter-defibrillators (ICDs) are underutilized, particularly in Asia, Latin America, Eastern Europe, the Middle East, and Africa. The Improve SCA trial demonstrated that primary prevention (PP) patients in these regions benefit from an ICD or a cardiac resynchronization therapy defibrillator (CRT-D). We aimed to compare the rate of device therapy and mortality among ischemic and non-ischemic cardiomyopathy (ICM and NICM) PP patients who met guideline indications for ICD therapy and had an ICD/CRT-D implanted...
January 31, 2023: Indian Heart Journal